Literature DB >> 14667974

Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system.

Luciano Martini1, Valerio Magnaghi, Roberto C Melcangi.   

Abstract

The sciatic nerve, and the Schwann cells in particular, are able to synthesize progesterone and possess the enzymes forming the 5alpha-reduced and the 3alpha-5alpha-reduced derivatives of progesterone: dihydroprogesterone and tetrahydroprogesterone. Moreover, the progesterone receptor (PR) is present in the sciatic nerve and in Schwann cell cultures. These facts suggest that progesterone and its derivatives might play a role in the control of the synthesis of the two major proteins of the peripheral nervous system (PNS): the glycoprotein Po (Po) and peripheral myelin protein 22 (PMP22). We have shown that: (a) dihydroprogesterone enhances the low mRNA levels of Po in the sciatic nerve of aged male rats; (b) progesterone and its derivatives stimulate the gene expression of Po in the sciatic nerve of adult rats and in Schwann cell cultures; (c) tetrahydroprogesterone increases PMP22 gene expression in the sciatic nerve of adult rats and in Schwann cell cultures. In additional experiments, utilizing agonists and antagonists of PR and GABAA receptor, we have observed that progesterone and its derivatives control Po gene expression via the PR, while tetrahydroprogesterone modulates the expression of PMP22 through the GABAA receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667974     DOI: 10.1016/s0039-128x(03)00134-x

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  12 in total

Review 1.  Neurogenic pain and steroid synthesis in the spinal cord.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Domitille Boudard; Véronique Schaeffer; Aurélie Béglé; Simona Saredi; Laurence Meyer; Ayikoe G Mensah-Nyagan
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

2.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

3.  Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception.

Authors:  Christine Patte-Mensah; Cherkaouia Kibaly; Ayikoe G Mensah-Nyagan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

4.  Impaired neurosteroid synthesis in multiple sclerosis.

Authors:  Farshid Noorbakhsh; Kristofor K Ellestad; Ferdinand Maingat; Kenneth G Warren; May H Han; Lawrence Steinman; Glen B Baker; Christopher Power
Journal:  Brain       Date:  2011-09       Impact factor: 13.501

5.  Progesterone - new therapy in mild carpal tunnel syndrome? Study design of a randomized clinical trial for local therapy.

Authors:  Paolo Milani; Mauro Mondelli; Federica Ginanneschi; Riccardo Mazzocchio; Alessandro Rossi
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2010-04-26

Review 6.  Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functions.

Authors:  Cheryl A Frye
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

7.  Regulatory role of cytochrome P450scc and pregnenolone in myelination by rat Schwann cells.

Authors:  Thant S Zhu; Michael Glaser
Journal:  Mol Cell Biochem       Date:  2008-03-31       Impact factor: 3.396

Review 8.  Progesterone receptors: form and function in brain.

Authors:  Roberta Diaz Brinton; Richard F Thompson; Michael R Foy; Michel Baudry; Junming Wang; Caleb E Finch; Todd E Morgan; Christian J Pike; Wendy J Mack; Frank Z Stanczyk; Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-02-23       Impact factor: 8.606

9.  The neurosteroid allopregnanolone modulates specific functions in central and peripheral glial cells.

Authors:  Alessandro Faroni; Valerio Magnaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-28       Impact factor: 5.555

10.  Neuroprotective actions of neurosteroids.

Authors:  Kinga K Borowicz; Barbara Piskorska; Monika Banach; Stanislaw J Czuczwar
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.